Cargando…

Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters

OBJECTIVE: This study investigated the feasibility of predicting the expression levels of Ki-67 in breast cancer using ultrasonographic findings and clinical features. METHODS: Fifty-eight breast cancer patients, with 82 lesions confirmed by surgical pathology, were selected retrospectively for this...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Chen, Zhao, Hongyan, Tian, Wei, Hu, Chunhong, Zhao, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520259/
https://www.ncbi.nlm.nih.gov/pubmed/34656085
http://dx.doi.org/10.1186/s12880-021-00684-3
_version_ 1784584632606392320
author Cheng, Chen
Zhao, Hongyan
Tian, Wei
Hu, Chunhong
Zhao, Haitao
author_facet Cheng, Chen
Zhao, Hongyan
Tian, Wei
Hu, Chunhong
Zhao, Haitao
author_sort Cheng, Chen
collection PubMed
description OBJECTIVE: This study investigated the feasibility of predicting the expression levels of Ki-67 in breast cancer using ultrasonographic findings and clinical features. METHODS: Fifty-eight breast cancer patients, with 82 lesions confirmed by surgical pathology, were selected retrospectively for this study. Conventional ultrasound examination and elastography examination were performed before surgery. Clinical features (age, estrogen receptor (ER), progesterone receptor, and human epidermal growth factor receptor-2 expression levels), ultrasonographic findings, and elastography scores, including the maximum size, location, number, margin, borderline, blood flow, and elastography score of the mass, were collected. The expression of Ki-67 was recorded using immunohistochemical staining, and the patients were divided into a high (≥ 20%) expression group and a low (< 20%) expression group. SPSS 23.0 software was used for statistical analysis. An independent sample t-test was used for measurement data, and a χ(2) test was used for enumeration data. Logistic regression analysis was performed for meaningful indicators, and the receiver operating characteristic curve was used to calculate the best diagnostic cut-off point. RESULTS: Monofactorial analysis showed that there was a statistically significant difference (p < 0.05) between the high expression of Ki-67 and the maximum diameter of the mass, the margin of the mass, the color Doppler flow imaging of the blood flow, and the resistance index of the blood flow. There were no significant differences in age, mass location, number, morphology, borderline, microcalcification, and elastography score (p > 0.05). Multiple factor regression analysis showed that a large mass and a mass with a rich blood flow had an independent predictive value for Ki-67. When the diameter was > 21.5 mm, the diagnostic sensitivity and specificity were 91.9% and 71.3%, respectively. The expression level of Ki-67 was negatively correlated with that of ER. CONCLUSION: The tumor size and blood flow of breast cancer is correlated with the expression level of Ki-67 and, thus, it could be used to predict the expression level of Ki-67 in ultrasound diagnosis. The margin condition and the expression level of ER of an ultrasonic mass could also indirectly reflect the Ki-67 expression level of the mass.
format Online
Article
Text
id pubmed-8520259
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85202592021-10-20 Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters Cheng, Chen Zhao, Hongyan Tian, Wei Hu, Chunhong Zhao, Haitao BMC Med Imaging Research OBJECTIVE: This study investigated the feasibility of predicting the expression levels of Ki-67 in breast cancer using ultrasonographic findings and clinical features. METHODS: Fifty-eight breast cancer patients, with 82 lesions confirmed by surgical pathology, were selected retrospectively for this study. Conventional ultrasound examination and elastography examination were performed before surgery. Clinical features (age, estrogen receptor (ER), progesterone receptor, and human epidermal growth factor receptor-2 expression levels), ultrasonographic findings, and elastography scores, including the maximum size, location, number, margin, borderline, blood flow, and elastography score of the mass, were collected. The expression of Ki-67 was recorded using immunohistochemical staining, and the patients were divided into a high (≥ 20%) expression group and a low (< 20%) expression group. SPSS 23.0 software was used for statistical analysis. An independent sample t-test was used for measurement data, and a χ(2) test was used for enumeration data. Logistic regression analysis was performed for meaningful indicators, and the receiver operating characteristic curve was used to calculate the best diagnostic cut-off point. RESULTS: Monofactorial analysis showed that there was a statistically significant difference (p < 0.05) between the high expression of Ki-67 and the maximum diameter of the mass, the margin of the mass, the color Doppler flow imaging of the blood flow, and the resistance index of the blood flow. There were no significant differences in age, mass location, number, morphology, borderline, microcalcification, and elastography score (p > 0.05). Multiple factor regression analysis showed that a large mass and a mass with a rich blood flow had an independent predictive value for Ki-67. When the diameter was > 21.5 mm, the diagnostic sensitivity and specificity were 91.9% and 71.3%, respectively. The expression level of Ki-67 was negatively correlated with that of ER. CONCLUSION: The tumor size and blood flow of breast cancer is correlated with the expression level of Ki-67 and, thus, it could be used to predict the expression level of Ki-67 in ultrasound diagnosis. The margin condition and the expression level of ER of an ultrasonic mass could also indirectly reflect the Ki-67 expression level of the mass. BioMed Central 2021-10-16 /pmc/articles/PMC8520259/ /pubmed/34656085 http://dx.doi.org/10.1186/s12880-021-00684-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cheng, Chen
Zhao, Hongyan
Tian, Wei
Hu, Chunhong
Zhao, Haitao
Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters
title Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters
title_full Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters
title_fullStr Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters
title_full_unstemmed Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters
title_short Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters
title_sort predicting the expression level of ki-67 in breast cancer using multi-modal ultrasound parameters
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520259/
https://www.ncbi.nlm.nih.gov/pubmed/34656085
http://dx.doi.org/10.1186/s12880-021-00684-3
work_keys_str_mv AT chengchen predictingtheexpressionlevelofki67inbreastcancerusingmultimodalultrasoundparameters
AT zhaohongyan predictingtheexpressionlevelofki67inbreastcancerusingmultimodalultrasoundparameters
AT tianwei predictingtheexpressionlevelofki67inbreastcancerusingmultimodalultrasoundparameters
AT huchunhong predictingtheexpressionlevelofki67inbreastcancerusingmultimodalultrasoundparameters
AT zhaohaitao predictingtheexpressionlevelofki67inbreastcancerusingmultimodalultrasoundparameters